Treatment of diabetic ketoacidosis: should mode of insulin administration dictate use of intensive care facilities?

Andrew R Hoffman, Romana M Haas

Journal: The American journal of medicine 2004;117(5):357-8

PMID: 15336586

Full Text on Elsevier Science View on PubMed

Abstract

DOI: 10.1016/j.amjmed.2004.06.020

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetesmedicines.html

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0002...

MeSH Terms: Cost-Benefit Analysis, Diabetic Ketoacidosis, Drug Monitoring, Hospital Charges, Humans, Hypoglycemic Agents, Infusions, Intravenous, Injections, Intravenous, Injections, Subcutaneous, Insulin, Intensive Care Units, Patient Selection, Safety, Treatment Outcome

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.